Fiona Hegi-Johnson

P1.10-02 ImmunoPET: A Phase 0/1 Study Characterising PD-L1 with 89Zr-Durvalumab (MEDI4736) PET/CT in Stage III NSCLC Patients Receiving Chemoradiation

M MacManus, S Rudd, P Roselt, C Wichmann, J Callahan, T John, A Scott, P Donnelly, G Hanna, F Hegi-Johnson

Journal article  |  2022  |  Journal of Thoracic Oncology

MA09.05 Increased PD-L1 Tracer Uptake in Recently-irradiated Lesions in NSCLC: Preliminary Results of a Phase 0 Trial (ImmunoPET) of a Novel PET Tracer

F Hegi-Johnson, T Akhurst, S Rudd, P Donnelly, A Scott, J Callahan, P Roselt, T John, S Sithara, C Wichmann, G Hanna, M MacManus

Journal article  |  2022  |  Journal of Thoracic Oncology

P2.03-01 Initial Biodistribution Data of ImmunoPET A Phase 0/1 Study Characterising PD-L1 with 89 Zr-Durvalumab (MEDI4736) PET/CT

F Hegi-Johnson, S Rudd, J Callahan, C Wichmann, T Akhurst, P Roselt, T John, P Donnelly, A Scott, G Hanna, M MacManus

Journal article  |  2022  |  Journal of Thoracic Oncology

Imaging immunity in patients with cancer using positron emission tomography

Fiona Hegi-Johnson, Stacey Rudd, Rodney J Hicks, Dirk De Ruysscher, Joseph A Trapani, Thomas John, Paul Donnelly, Benjamin Blyth, Gerard Hanna, Sarah Everitt, Peter Roselt, Michael P MacManus

Journal article  |  2022  |  NPJ PRECISION ONCOLOGY

Immune checkpoint inhibitors and related molecules can achieve tumour regression, and even prolonged survival, for a subset of can..

Please Place Your Seat in the Full Upright Position: A Technical Framework for Landing Upright Radiation Therapy in the 21(st) Century

Sarah Hegarty, Nicholas Hardcastle, James Korte, Tomas Kron, Sarah Everitt, Sulman Rahim, Fiona Hegi-Johnson, Rick Franich

Journal article  |  2022  |  FRONTIERS IN ONCOLOGY

Delivering radiotherapy to patients in an upright position can allow for increased patient comfort, reduction in normal tissue irr..

Overcoming immunotherapy resistance in NSCLC

Michael MacManus, Fiona Hegi-Johnson

Journal article  |  2022  |  LANCET ONCOLOGY

Fully Automated Radiosynthesis of [Zr-89]Zr-DFOSq-Durvalumab for Clinical PET Imaging of PD-L1

C Wichmann, S Poniger, N Guo, P Roselt, S Rudd, PS Donnelly, F Hegi-Johnson, M MacManus, AM Scott

Conference Proceedings  |  2021  |  EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Automated radiosynthesis of [Zr-89]ZrDFOSq-Durvalumab on the iPHASE MultiSyn module

Christian Wichmann, Stan Poniger, Nancy Guo, Peter Roselt, Stacey Rudd, Paul Donnelly, Fiona Hegi-Johnson, Michael MacManus, Andrew Scott

Conference Proceedings  |  2021  |  JOURNAL OF NUCLEAR MEDICINE

AUTOMATED RADIOSYNTHESIS OF [(89)ZR]ZR-DFOSQ-DURVALUMAB ON THE IPHASE MULTISYN MODULE

C Wichmann, S Poniger, N Guo, P Roselt, S Rudd, P Donnelly, F Hegi-Johnson, M MacManus, A Scott

Conference Proceedings  |  2021  |  INTERNAL MEDICINE JOURNAL

Impact of Primary Subtype on Pattern of Metastases and Survival in Young Women with Metastatic Breast Cancer

R Alomran, J Xie, F Hegi-Johnson, J Philip, PKL Tran

Conference Proceedings  |  2020  |  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS